Hematuria due to adenoviral infection in bone marrow transplant recipients

Transplant Proc. 2010 Nov;42(9):3729-34. doi: 10.1016/j.transproceed.2010.08.049.

Abstract

Late-onset hemorrhagic cystitis (HC) caused by adenovirus (AdV) infection is a common complication in hematopoietic stem cell transplantation (HSCT) recipients. However, limited information exists regarding adenovirus-associated HC. We report a retrospective study of 84 hematopoietic stem cell transplant recipients that evaluated the incidence and risk factors for AdV-induced HC. The development of HC was strongly related to adenoviral infection (P = .004). Among 13 patients who developed late-onset HC, AdVs were identified as a causative agent in 10 cases. AdV preferentially affected younger (P = .013) and male patients. Affected subjects had been transplanted for either malignant (7/10) or nonmalignant disorders (3/10). Most cases of AdV-hematuria were self-limited single or recurrent mild hemorrhagic episodes (P = .000), occurring at a median of 41 days after transplantation and lasting an average of 4 days. Viral load in patients with AdV-induced HC was similar to infected subjects who did not develop HC (2.5 × 10(3) vs 3.4 × 10(3) copies/mL). We HC occurring before 200 days was associated with a greater risk of a fatal outcome (P = .002) but occurrence of AdV infection did not affect a patient's survival. Our study confirmed the suggestion that non-AdV coinfections may worsen the course of AdV-HC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / genetics
  • Adenoviridae / isolation & purification*
  • Adenoviridae Infections / diagnosis
  • Adenoviridae Infections / mortality
  • Adenoviridae Infections / virology*
  • Adolescent
  • Adult
  • Bone Marrow Transplantation / adverse effects*
  • Bone Marrow Transplantation / mortality
  • Chi-Square Distribution
  • Child
  • Child, Preschool
  • Cystitis / mortality
  • Cystitis / virology*
  • DNA, Viral / isolation & purification
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hematopoietic Stem Cell Transplantation / mortality
  • Hematuria / mortality
  • Hematuria / virology*
  • Hemorrhage / mortality
  • Hemorrhage / virology*
  • Humans
  • Incidence
  • Infant
  • Kaplan-Meier Estimate
  • Male
  • Poland
  • Polymerase Chain Reaction
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Viral Load
  • Young Adult

Substances

  • DNA, Viral